- Home
- BBIO vs SKYW Comparison
BBIO vs SKYW Comparison
Compare BBIO & SKYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBIO | SKYW |
|---|---|---|
| Founded | 2015 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3B | 3.7B |
| IPO Year | 2019 | 1994 |
Fundamental Metrics
Financial Performance| Metric | BBIO | SKYW |
|---|---|---|
| Price | $69.44 | $89.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 24 | 4 |
| Target Price | $83.00 | ★ $124.75 |
| AVG Volume (30 Days) | ★ 2.8M | 251.5K |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.20 |
| EPS | N/A | ★ 10.35 |
| Revenue | $502,076,000.00 | ★ $2,971,963,000.00 |
| Revenue This Year | $88.86 | $8.20 |
| Revenue Next Year | $74.11 | $3.80 |
| P/E Ratio | ★ N/A | $8.64 |
| Revenue Growth | ★ 126.26 | N/A |
| 52 Week Low | $28.33 | $74.70 |
| 52 Week High | $84.94 | $123.94 |
Technical Indicators
Market Signals| Indicator | BBIO | SKYW |
|---|---|---|
| Relative Strength Index (RSI) | 49.17 | 30.67 |
| Support Level | $61.95 | N/A |
| Resistance Level | $79.56 | $103.63 |
| Average True Range (ATR) | 3.33 | 3.59 |
| MACD | 0.53 | -1.54 |
| Stochastic Oscillator | 50.86 | 7.46 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About SKYW SkyWest Inc.
SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. SkyWest generally provides regional flights and utilizes smaller, lower-cost aircraft to carry passengers who book tickets through partner airlines. It partners with carriers to fly and operate aircraft for a fee and may use the carriers' brands and ground support to coordinate marketing and transport passengers. The company has two reportable segments: SkyWest Airlines and SWC, which generate maximum revenue, and SkyWest Leasing activities.